Clinical Trial Update: Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating the combination of docetaxel and S-1 as second-line therapy for advanced gastric cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Advanced Gastric Cancer | Phase 2 | Status: UNKNOWN